Could a vitamin B1 derivative slow Alzheimer's? new trial seeks answers
Disease control
Recruiting now
This study tests whether benfotiamine, a form of vitamin B1, can safely slow memory and thinking decline in people with early Alzheimer's disease. About 406 adults aged 50-89 with mild cognitive impairment or mild dementia will receive either the drug or a placebo for up to 72 we…
Phase: PHASE2 • Sponsor: Alzheimer's Disease Cooperative Study (ADCS) • Aim: Disease control
Last updated May 04, 2026 00:52 UTC